These findings led us to postulate that downregulation of O‐GlcNAcylation due to lower glucose uptake may suppress PKA‐CREB signaling and consequently contribute to memory loss and cognitive decline in AD. The gene discussed is CREB1; the disease is Alzheimer disease.